Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
Clinical trial NCT07215910 · RECRUITING
Trial details
- NCT number
- NCT07215910
- Sponsor
- Alliance for Clinical Trials in Oncology
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-20
- Primary completion
- 2033-05-31
- Enrollment
- 408
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.